ABEO - Abeona Therapeutics Inc
5.34
-0.050 -0.936%
Share volume: 597,632
Last Updated: 04-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$5.39
-0.05
-0.01%
Summary score
57%
Profitability
53%
Dept financing
28%
Liquidity
75%
Performance
65%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-13.82%
Return on sales
-5366.29%
Return on invested capital
0%
Total debt ratio
58.23%
Debt ratio change over timeo
0%
Current Ratio
5.58%
Quick Ratio
7.64%
Cash Position Ratio
1.57%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
6.66%
Return on sales
-3060.36%
Return on invested capital
0%
Total debt ratio
36.32%
Debt ratio change over timeo
0%
Current Ratio
7.08%
Quick Ratio
7.64%
Cash Position Ratio
3%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
59.74%
Return on sales
-422.71%
Return on invested capital
0%
Total debt ratio
27.49%
Debt ratio change over time
0%
Current Ratio
6.93%
Quick Ratio
6.74%
Cash Position Ratio
2.65%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABEO | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -13.82% | 4.74% | 3.19% | 1.73% |
| Return on sales | -5366.29% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 58.23% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 0% | -20.57% | -85.61% | 17.33% |
| Dept financing | 15% | 21% | 16% | 50% |
| Current Ratio | 7.08% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 7.64% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 3% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 11% | 16% | 10% |
| Short-term ratios | ABEO | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 6.66% | 6.06% | 4.18% | 1.7% |
| Return on sales | -3060.36% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 48% | 33% | 22% |
| Total debt ratio | 36.32% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 34% | 20% | 15% | 25% |
| Current Ratio | 7.08% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 7.64% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 3% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 10% | 10% | 6% |